Publications en collaboration avec des chercheurs de Universidad CEU San Pablo (256)

2024

  1. Comparative environmental assessment of coated ferritic steels suited to steam turbines of coal-fired supercritical and ultra-supercritical power plants

    Journal of Cleaner Production, Vol. 443

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  3. Optimisation of the electrochemical performance of (Nd,Gd)1/3Sr2/3CoO3−δ cathode for solid oxide fuel cells via spray-pyrolysis deposition and decoration with Ag nanoparticles

    Journal of Materials Chemistry A

  4. The Potential of Plum Seed Residue: Unraveling the Effect of Processing on Phytochemical Composition and Bioactive Properties

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

  5. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review

    Talanta, Vol. 269

2023

  1. Monte Carlo simulations and molecular discrete perturbation theory of multipolar oblate Kihara fluids

    Journal of Molecular Liquids, Vol. 383

  2. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 11, pp. 2851-2874

  3. Revealing the Specificity of Human H1 Influenza A Viruses to Complex N-Glycans

    JACS Au, Vol. 3, Núm. 3, pp. 868-878

  4. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203

  5. Stability and Evolution of the Crystal Structure of TbBaCo2O6−δ During Thermal Oxygen Release/Uptake

    Inorganic Chemistry, Vol. 62, Núm. 1, pp. 247-255

2022

  1. EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 1, pp. 17-38

  2. The impact of type 2 immunity and allergic diseases in atherosclerosis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 11, pp. 3249-3266

2021

  1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy

    Clinical and Translational Allergy, Vol. 11, Núm. 4

  2. Aradyal: The spanish multidisciplinary research network for allergic diseases

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 108-119

  3. COVID-19 pandemic and allergen immunotherapy—an EAACI survey

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 11, pp. 3504-3516

  4. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 648-676

  5. EAACI Biologicals Guidelines—Recommendations for severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44

  6. EAACI Biologicals Guidelines—dupilumab for children and adults with moderate-to-severe atopic dermatitis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 988-1009

  7. Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 45-58

  8. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 8, pp. 2337-2353